Skip to main content
Sailong Pharmaceutical Group Co., Ltd. logo

Sailong Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 002898 ISIN · CNE1000032S5 LEI · 8368004F5Y6BSB6US681 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,116 across all filing types
Latest filing 2024-10-07 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002898

About Sailong Pharmaceutical Group Co., Ltd.

https://www.sailong.cn

Sailong Pharmaceutical Group Co., Ltd. is a pharmaceutical enterprise focused on the research, development, production, and marketing of high-end generic drugs and innovative formulations. The company maintains an integrated industrial chain encompassing active pharmaceutical ingredients (APIs) and finished dosage forms. Its product portfolio primarily targets therapeutic areas such as cardiovascular and cerebrovascular diseases, the digestive system, and anti-infective treatments. Key products include Monosialotetrahexosylganglioside Sodium Injection and Pantoprazole Sodium for Injection. The group emphasizes technological innovation and quality control to provide clinical solutions for complex medical conditions.

Recent filings

Filing Released Lang Actions
关于子公司获得化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about its subsidiary receiving an approval notice from a regulatory authority (National Medical Products Administration) for a chemical raw material drug listing application. It contains no financial data, no detailed report or analysis, and is relatively short (697 characters). It is an announcement of a regulatory approval event, not a financial report or detailed filing. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it does not mention any report being published or attached. The content is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a business event that does not fit other specific categories.
2024-10-07 Chinese
关于《总部项目合作协议》及其补充协议的进展公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about the progress and completion of property and parking space handover under previously signed cooperation agreements. It details the signing of agreements, confirmation of compliance with original terms, and the impact on the company. The document is relatively short (1795 characters) and serves as a progress update on a specific project rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or regulatory certifications. It is not a report itself but an announcement about the progress of a project and related agreements. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-09-27 Chinese
关于子公司获得化学原料药上市申请批准通知书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining approval for a chemical raw material drug listing application from the National Medical Products Administration. It contains no financial data, no report or financial statements, and is not a meeting material or voting result. It is a regulatory announcement about a business development event. The document length is short (729 characters) and it is an announcement of an approval notice, not a report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-09-25 Chinese
第四届董事会第五次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the fifth meeting of the fourth board of directors of the company. It includes details about the meeting's notification, attendance, and voting results on a proposal to convene a shareholders' meeting. There is no financial data, audit information, or detailed report content. The document is an announcement related to board/management decisions and meeting outcomes, not a full report or financial statement. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on board meeting resolutions, confirming this classification.
2024-09-24 Chinese
第四届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolution from the fourth meeting of the fourth Supervisory Board of Sailong Pharmaceutical Group Co., Ltd. It details the meeting's convening, attendance, and the approval of a proposal to nominate a new non-employee representative supervisor due to a resignation. It includes voting results and mentions that the proposal will be submitted to the shareholders' meeting for approval. The document is an official announcement of board/management changes and decisions, not a full report or financial statement. It fits the category of Board/Management Information (MANG). The document length is short and focused on governance matters, not financial results or regulatory filings.
2024-09-24 Chinese
关于召开2024年第四次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2024 fourth extraordinary general meeting of shareholders for a company, including details about the meeting date, voting procedures, agenda items, and proxy forms. It does not contain financial statements or results but is an announcement related to a shareholder meeting. The document length is 3504 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2024-09-24 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.